Browse studies

Find your next paid study

27,300 recruiting studies available now

Rare Kidney Stone Consortium Biobank, Rare Diseases Clinical Research Network

This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent…

Primary HyperoxaluriaDent DiseaseAPRT Deficiency+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT02026388

Phase 1

A Phase 1A/B Study To Evaluate The Safety And Tolerability Of EBC-129 As A Single Agent And In Combination With Pembrolizumab In Advanced Solid Tumours

This study will assess the safety and tolerability of EBC-129 as a single agent and in combination with pembrolizumab in patients with advanced solid tumours

Advanced Solid Tumours

Estimated

~$150 – $4,500

Actual pay is set by the research site.

EDDC (Experimental Drug Development Centre), A*STAR Research EntitiesNCT05701527

Phase 3

A Phase 3, Multicenter, Randomized, Controlled, Open-Label Clinical Trial of Aglatimagene Besadenovec (CAN-2409) Plus Prodrug and Pembrolizumab Versus Docetaxel for Stage IV Non-Squamous Non-Small Cell Lung Cancer Progressing on Pembrolizumab-based Treatment

This phase III trial compares the effect of the combination of aglatimagene besadenovec and pembrolizumab versus standard of care docetaxel chemotherapy for th…

Non-squamous, Non-Small Cell Lung Cancer

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Candel Therapeutics, Inc.NCT07660094

Observational

Identifying Challenges to Healthy Aging in Persons With HIV Age 50 and Older

The primary objective of this study is to identify and characterize frailty and pre-frailty in persons age 50 and older living with human immunodeficiency viru…

HIVAging

Estimated

~$10 – $750

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT05858034

Edwards PASCAL Transcatheter Tricuspid Valve Repair System Coverage With Evidence Development Study (The CLASP III TR CED Study)

This Coverage with Evidence Development (CED) study measures the long-term health outcomes of patients with severe, symptomatic Tricuspid Regurgitation who rec…

Tricuspid RegurgitationHeart Valve DiseasesHeart Diseases+2 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Edwards LifesciencesNCT07859709

Observational

Non-invasive Brain-computer Interfaces for Control of Assistive Devices

Injuries affecting the central nervous system may disrupt the cortical pathways to muscles causing loss of motor control. Nevertheless, the brain still exhibit…

Motor DisordersHealthySpinal Cord Injuries+6 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Texas at AustinNCT05183152

Phase 1

Phase Ib Study of Anti-CD3 x Anti-CD33 Bispecific Antibody (CD33Bi) Armed Fresh Peripheral Blood Mononuclear Cells (CD33 FPBMC) in Patients With Measurable Residual Disease (MRD)+ Acute Myeloid Leukemia or Myelodysplastic Syndrome

The purpose of this study is to understand the safety and estimate the efficacy of combining anti-CD3 x anti-CD33 bispecific antibody (CD33Bi) armed fresh peri…

Acute Myeloid LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasm

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of VirginiaNCT07270978

Phase 2

Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia (The ALIGN-AML Trial)

This is a phase 2 randomized controlled trial to evaluate whether a geriatric assessment (GA)-guided treatment strategy reduces treatment-related toxicity and …

Acute Myeloid Leukemia

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of RochesterNCT07735208

Phase 3

A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)

This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or g…

GanglioneuroblastomaGanglioneuroblastoma, NodularNeuroblastoma

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Children's Oncology GroupNCT03126916

Observational

Effects of Remote Ischemic Conditioning Combined With Motor Training on Spinal Reflex Modulation in Healthy Young Adults

Remote ischemic conditioning (RIC) is a clinically feasible method that protects distant organs from severe injury through brief, sub lethal periods of ischemi…

Healthy Young Adults

Estimated

~$10 – $750

Actual pay is set by the research site.

East Carolina UniversityNCT06860464

Phase 3

Open Label Extension Clinical Trial of Vormatrigine in Adult Patients With Epilepsy

Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy

Epilepsy, Tonic-ClonicFocal SeizurePrimary Generalized Seizure

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Praxis Precision MedicinesNCT07287163

Phase 2

Use of Metformin in Patients With Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms

This is a pilot, open-label clinical trial determining the feasibility of metformin therapy in subjects with pseudomyxoma peritonei (PMP) secondary to appendic…

Appendiceal Mucinous NeoplasmPseudomyxoma Peritonei

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of California, IrvineNCT07693452